Screener
Bright Minds Biosciences DRUG Q1 2026 earnings
Reported May 20, 2026 · Before market open
EPS-$0.80Beat by $0.37
EPS estimate-$1.17
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did Bright Minds Biosciences report Q1 2026 earnings?
- Bright Minds Biosciences (DRUG) reported Q1 2026 earnings on May 20, 2026 before market open.
- What were Bright Minds Biosciences's Q1 2026 revenue and EPS?
- Bright Minds Biosciences reported eps of $-0.80 for Q1 2026.
- Did Bright Minds Biosciences beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-1.17 by $0.37.
- How did Bright Minds Biosciences's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 50.9% from $-0.53.
